Altasciences Featured Webinars
-
Aseptic Processing Or Terminal Sterilization ― What's More Suitable?
3/4/2025
Regulatory agencies prefer terminal sterilization over aseptic manufacturing, but is it suitable for your product? Industry manufacturing experts guide you in the selection and final delivery.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs
2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates
2/20/2025
Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.
-
Overcoming The Challenges Of Manufacturing And Clinical Trials
8/20/2024
<p>Learn how CROs and CDMOs work in tandem to successfully address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.</p>
-
The Development Of Nanosuspension Formulations For Poorly Soluble Drugs
6/7/2024
Learn about key topics in nanomilling, including practical applications and advantages, specialized equipment, milling media, stabilizers, as well as manufacturing and scale-up considerations.
-
Manufacturing Solutions Using Hard-Shell, Liquid-Filled Capsules
1/11/2024
Discover the advantages of LFHCs, including improved solubility and bioavailability, enhanced stability, and customizable release profiles, and how they can accelerate drug development timelines.
-
Overcoming Challenges Of Manufacturing For Clinical Trials
1/11/2024
Learn how CROs and CDMOs work in tandem to address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.
-
Developing Nanosuspension Formulations For Poorly Soluble Drugs
1/11/2024
Learn more about the benefits of nanomilling, types of milling media and stabilizers, and scale up for clinical manufacturing.